Inventor · disambiguated record
Anke Klippel-Giese
Also filed as: KLIPPEL-GIESE ANKE
18 granted patents·9 pending applications·552 citations·filing 2003–2023
96Inventor score
Files withSILENCE THERAPEUTICS GMBH11SILENCE THERAPEUTICS AG AG5KLIPPEL-GIESE ANKE4PETRA PHARMA CORP2ATUGEN AG1
Top patents by PatentIndex Score
27 records- 0198US9695423B2Interfering RNA moleculesSILENCE THERAPEUTICS GMBH·Filed 2015·Granted Jul 4, 2017·46 cites·25 claims
- 0298US9222092B2Interfering RNA moleculesSILENCE THERAPEUTICS AG AG·Filed 2014·Granted Dec 29, 2015·76 cites·10 claims
- 0398US7452987B2Interfering RNA moleculesSILENCE THERAPEUTICS AG AG·Filed 2003·Granted Nov 18, 2008·183 cites·7 claims
- 0497US8933215B2Interfering RNA moleculesSILENCE THERAPEUTICS AG AG·Filed 2012·Granted Jan 13, 2015·43 cites·19 claims
- 0597US7893245B2Interfering RNA moleculesSILENCE THERAPEUTICS AG AG·Filed 2008·Granted Feb 22, 2011·80 cites·11 claims
- 0695US9790505B2Interfering RNA moleculesSILENCE THERAPEUTICS GMBH·Filed 2017·Granted Oct 17, 2017·10 cites·23 claims
- 0795US8324370B2Interfering RNA moleculesGIESE KLAUS·Filed 2011·Granted Dec 4, 2012·46 cites·23 claims
- 0892US9790501B2Interfering RNA moleculesSILENCE THERAPEUTICS GMBH·Filed 2017·Granted Oct 17, 2017·6 cites·30 claims
- 0992US9758784B1Interfering RNA moleculesSILENCE THERAPEUTICS GMBH·Filed 2017·Granted Sep 12, 2017·6 cites·24 claims
- 1092US7713943B2Further use of protein kinase N betaSILENCE THERAPEUTICS AG AG·Filed 2003·Granted May 11, 2010·44 cites·32 claims
- 1191US9783802B2Interfering RNA moleculesSILENCE THERAPEUTICS GMBH·Filed 2017·Granted Oct 10, 2017·5 cites·28 claims
- 1286US10329568B2Interfering RNA moleculesSILENCE THERAPEUTICS GMBH·Filed 2018·Granted Jun 25, 2019·2 cites·24 claims
- 1386US10323246B2Interfering RNA moleculesSILENCE THERAPEUTICS GMBH·Filed 2017·Granted Jun 18, 2019·2 cites·30 claims
- 1486US10266829B2Interfering RNA moleculesSILENCE THERAPEUTICS GMBH·Filed 2018·Granted Apr 23, 2019·2 cites·23 claims
- 1581US11649227B2Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of diseasePETRA PHARMA CORP·Filed 2021·Granted May 16, 2023·1 cites·20 claims
- 1678US10774332B2Interfering RNA moleculesSILENCE THERAPEUTICS GMBH·Filed 2019·Granted Sep 15, 2020·0 cites·24 claims
- 1777US11578328B2Interfering RNA moleculesSILENCE THERAPEUTICS GMBH·Filed 2020·Granted Feb 14, 2023·0 cites·13 claims
- 1866US2023286960A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2023·Application pending·0 cites
- 1953US9078855B2Further use of protein kinase N betaKLIPPEL-GIESE ANKE·Filed 2012·Granted Jul 14, 2015·0 cites·8 claims
- 2052US2015337382A1Further use of protein kinase n betaSILENCE THERAPEUTICS GMBH·Filed 2015·Application pending·0 cites
- 2150US2011008320A1Further Use of Protein Kinase N BetaSILENCE THERAPEUTICS AG·Filed 2010·Application pending·0 cites
- 2249US2003135033A1Compounds and methods for the identification and/ or validation of a targetFiled 2003·Application pending·0 cites
- 2346US2006240022A1Factor involved in metastasis and uses thereofATUGEN AG·Filed 2003·Application pending·0 cites
- 2440US2021147570A1Anticancer combination therapy with cd73 antagonist antibody and pd-1/pd-l1 axis antagonist antibodyBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 2534US2012100561A1A pkn3/rhoc macromolecular complex and methods of use thereforKLIPPEL-GIESE ANKE·Filed 2010·Application pending·0 cites
- 2633US2010285038A1Factor Involved in Metastasis and Uses ThereofKLIPPEL-GIESE ANKE·Filed 2010·Application pending·0 cites
- 2732US2013065928A1Biomarkers for pi3k-driven cancerKLIPPEL-GIESE ANKE·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anke Klippel-Giese files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →